| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 44, 595-598, Copyright © 1977 by Endocrine Society
ARTICLES |
MF Holick, MC de Blanco, MB Clark, JW Henley, RM Neer, HF DeLuca and JT Potts Jr
To evaluate whether 1alpha-hydroxycholecalciferol is metabolized to 1alpha,25-dihydroxycholecalciferol in man, [6-3H]1alpha- hydroxycholecalciferol was given intravenously to a patient with renal failure who was maintained daily on 100,000 IU vitamin D and calcium supplements. Using Sephadex LH-20 and high-pressure liquid chromatography, it was clearly demonstrated that 1alpha- hydroxycholecalciferol rapidly disappears from the blood and is metabolized to 1alpha,25-dihydroxycholecalciferol.
This article has been cited by other articles:
![]() |
L. Brandi, M. Egfjord, and K. Olgaard Pharmacokinetics of 1,25(OH)2D3 and 1{alpha}(OH)D3 in normal and uraemic men Nephrol. Dial. Transplant., May 1, 2002; 17(5): 829 - 842. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |